ÖÐÎÄÃû³Æ£º Íÿ¹RPS6KA1(Phospho-Thr573) ¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-RPS6KA1(Phospho-Thr573) rabbit polyclonal antibody
±ð Ãû£º RSK; HU-1; RSK1; MAPKAPK1A
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â
ËÞ Ö÷£º Rabbit
¿¹ Ô£º RPS6KA1(Phospho-Thr573)
·´Ó¦ÖÖÊô£º Human
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
RPS6KA1(Phospho-Thr573) |
|
Immunogen: |
Peptide sequence around phosphorylation site of threonine 573(L-M-T(p)-P-C) derived from Human p90 RSK. |
|
Full name: |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
|
Synonyms£º |
RSK; HU-1; RSK1; MAPKAPK1A |
|
SwissProt: |
Q15418 |
|
IHC positive control: |
Human breast carcinoma tissue |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
83 kDa |
|
WB Positive control: |
293 cells lysates treated with UV |
|
WB Recommended dilution: |
500-1000 |

¹ºÎï³µ
°ïÖú
021-54845833/15800441009
